{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:39:31Z","timestamp":1790120371997,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,17]]},"DOI":"10.7759\/cureus.20483","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T15:04:41Z","timestamp":1639753481000},"source":"Crossref","is-referenced-by-count":17,"title":["The Efficacy of Probiotics in the Management of Helicobacter Pylori: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Sai Sri","family":"Penumetcha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saher","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejja","family":"Irfan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawleha Arshi","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Rohit Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elisa","family":"Vasquez Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Busmail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"Prevalence of antibiotic resistance in Helicobacter pylori: a\u00a0systematic review and meta-analysis in World Health Organization regions","volume":"155","author":"Savoldi A","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E. Prevalence of antibiotic resistance in Helicobacter pylori: a\u00a0systematic review and meta-analysis in World Health Organization regions. Gastroenterology. 2018, 155:1372-82.e17. 10.1053\/j.gastro.2018.07.007","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i1.139","article-title":"Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis","volume":"24","author":"Losurdo G","year":"2018","unstructured":"Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A. Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis. Wr J Gastro. 2018, 24:139-49. 10.3748\/wjg.v24.i1.139","journal-title":"Wr J Gastro"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2019.20.9.2859","article-title":"High effective of 14-day high-dose PPI- bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: a double blinded-randomized placebo-controlled study","volume":"20","author":"Poonyam P","year":"2019","unstructured":"Poonyam P, Chotivitayatarakorn P, Vilaichone RK. High effective of 14-day high-dose PPI- bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: a double blinded-randomized placebo-controlled study. Asi Pac J Can Prev. 2019, 20:2859-64. 10.31557\/APJCP.2019.20.9.2859","journal-title":"Asi Pac J Can Prev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2050640615617358","article-title":"Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events","volume":"4","author":"McFarland LV","year":"2016","unstructured":"McFarland LV, Huang Y, Wang L, Malfertheiner P. Systematic review and meta-analysis: multi-strain probiotics as adjunct therapy for Helicobacter pylori eradication and prevention of adverse events. United European Gastroenterol J. 2016, 4:546-61. 10.1177\/2050640615617358","journal-title":"United European Gastroenterol J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005573.pub3","article-title":"Probiotics for induction of remission in ulcerative colitis","volume":"3","author":"Kaur L","year":"2020","unstructured":"Kaur L, Gordon M, Baines PA, Iheozor-Ejiofor Z, Sinopoulou V, Akobeng AK. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020, 3:CD005573. 10.1002\/14651858.CD005573.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-017-8535-7","article-title":"Helicobacter pylori treatment: antibiotics or probiotics","volume":"102","author":"Goderska K","year":"2018","unstructured":"Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018, 102:1-7. 10.1007\/s00253-017-8535-7","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3409820","article-title":"Role of probiotics in Helicobacter pylori eradication: lessons from a study of Lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 (Gastrus\u00ae) and a proton-pump inhibitor","volume":"2019","author":"Dore MP","year":"2019","unstructured":"Dore MP, Bibb\u00f2 S, Pes GM, Francavilla R, Graham DY. Role of probiotics in Helicobacter pylori eradication: lessons from a study of Lactobacillus reuteri strains DSM 17938 and ATCC PTA 6475 (Gastrus\u00ae) and a proton-pump inhibitor. Can J Infect Dis Med Microbiol. 2019, 2019:3409820. 10.1155\/2019\/3409820","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016601","article-title":"Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study","volume":"98","author":"Yoon JY","year":"2019","unstructured":"Yoon JY, Cha JM, Hong SS, Kim HK, Kwak MS, Jeon JW, Shin HP. Fermented milk containing Lactobacillus paracasei and Glycyrrhiza glabra has a beneficial effect in patients with Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019, 98:e16601. 10.1097\/MD.0000000000016601","journal-title":"Medicine (Baltimore)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.08.028","article-title":"The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, randomized clinical trial","volume":"35","author":"Chen L","year":"2018","unstructured":"Chen L, Xu W, Lee A, et al.. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, randomized clinical trial. Lancet. 2018, 35:87-96. 10.1016\/j.ebiom.2018.08.028","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15406\/ghoa.2020.11.00444","article-title":"Sequential therapy for Helicobacter pylori infection with and without probiotics","volume":"11","author":"Rafiei R","year":"2020","unstructured":"Rafiei R, Ebrahimi A, Bahrami M, et al.. Sequential therapy for Helicobacter pylori infection with and without probiotics. Gastroenterol Hepatol Open Access. 2020, 11:231-234. 10.15406\/ghoa.2020.11.00444","journal-title":"Gastroenterol Hepatol Open Access"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2021.03.001","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"134","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021, 134:178-89. 10.1016\/j.jclinepi.2021.03.001","journal-title":"J Clin Epidemiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023131","article-title":"Efficacy of compound Lactobacillus acidophilus tablets combined with quadruple therapy for Helicobacter pylori eradication and its correlation with pH value in the stomach: a study protocol of a randomised, assessor-blinded, single-centre study","volume":"8","author":"Ji W","year":"2018","unstructured":"Ji W, Chen WQ, Tian X. Efficacy of compound Lactobacillus acidophilus tablets combined with quadruple therapy for Helicobacter pylori eradication and its correlation with pH value in the stomach: a study protocol of a randomised, assessor-blinded, single-centre study. BMJ Open. 2018, 8:e023131. 10.1136\/bmjopen-2018-023131","journal-title":"BMJ Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2011.06985.x","article-title":"Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy","volume":"27","author":"Deguchi R","year":"2012","unstructured":"Deguchi R, Nakaminami H, Rimbara E, et al.. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. J Gastroenterol Hepatol. 2012, 27:888-92. 10.1111\/j.1440-1746.2011.06985.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022976","article-title":"The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: an open-label, single-arm pilot study","volume":"99","author":"Zhang J","year":"2020","unstructured":"Zhang J, Guo J, Li D, et al.. The efficacy and safety of Clostridium butyricum and Bacillus coagulans in Helicobacter pylori eradication treatment: an open-label, single-arm pilot study. Medicine (Baltimore). 2020, 99:e22976. 10.1097\/MD.0000000000022976","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4052","article-title":"Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis","volume":"351","author":"Li BZ","year":"2015","unstructured":"Li BZ, Threapleton DE, Wang JY, et al.. Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. BMJ. 2015, 351:h4052. 10.1136\/bmj.h4052","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015180","article-title":"Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis","volume":"98","author":"Shi X","year":"2019","unstructured":"Shi X, Zhang J, Mo L, Shi J, Qin M, Huang X. Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis. Medicine (Baltimore). 2019, 98:e15180. 10.1097\/MD.0000000000015180","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14539","article-title":"Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus","volume":"47","author":"Hungin AP","year":"2018","unstructured":"Hungin AP, Mitchell CR, Whorwell P, et al.. Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus. Aliment Pharmacol Ther. 2018, 47:1054-70. 10.1111\/apt.14539","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","article-title":"Helicobacter pylori infection: old and new","volume":"10","author":"Diaconu S","year":"2017","unstructured":"Diaconu S, Predescu A, Moldoveanu A, Pop CS, Fierbin\u021beanu-Braticevici C. Helicobacter pylori infection: old and new. J Med Life. 2017, 10:112-7.","journal-title":"J Med Life"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi JK","year":"2017","unstructured":"Hooi JK, Lai WY, Ng WK, et al.. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology . 2017, 153:420-9. 10.1053\/j.gastro.2017.04.022","journal-title":"Gastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12251","article-title":"Pathogenesis of Helicobacter pylori infection","volume":"20","author":"Sgouras DN","year":"2015","unstructured":"Sgouras DN, Trang TT, Yamaoka Y. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2015, 20:8-16. 10.1111\/hel.12251","journal-title":"Helicobacter"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2857","article-title":"Helicobacter pylori: gastric cancer and beyond","volume":"10","author":"Polk DB","year":"2010","unstructured":"Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer. 2010, 10:403-14. 10.1038\/nrc2857","journal-title":"Nat Rev Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i29.3204","article-title":"Helicobacter pylori and extragastric diseases: a review","volume":"24","author":"Gravina AG","year":"2018","unstructured":"Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: a review. Wr J Gastroenterol. 2018, 24:3204-21. 10.3748\/wjg.v24.i29.3204","journal-title":"Wr J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13497","article-title":"Review article: the global emergence of Helicobacter pylori antibiotic resistance","volume":"43","author":"Thung I","year":"2016","unstructured":"Thung I, Aramin H, Vavinskaya V, Gupta S, Park JY, Crowe SE, Valasek MA. Review article: the global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016, 43:514-33. 10.1111\/apt.13497","journal-title":"Aliment Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00168","article-title":"Novel and effective therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance","volume":"7","author":"Hu Y","year":"2017","unstructured":"Hu Y, Zhu Y, Lu NH. Novel and effective therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance. Front Cell Infect Microbiol. 2017, 7:168. 10.3389\/fcimb.2017.00168","journal-title":"Front Cell Infect Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-018-09580-3","article-title":"Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?","volume":"103","author":"Qureshi N","year":"2019","unstructured":"Qureshi N, Li P, Gu Q. Probiotic therapy in Helicobacter pylori infection: a potential strategy against a serious pathogen?. Appl Microbiol Biotechnol. 2019, 103:1573-88. 10.1007\/s00253-018-09580-3","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163743","article-title":"Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials","volume":"11","author":"L\u00fc M","year":"2016","unstructured":"L\u00fc M, Yu S, Deng J, Yan Q, Yang C, Xia G, Zhou X. Efficacy of probiotic supplementation therapy for Helicobacter pylori eradication: a meta-analysis of randomized controlled trials. PLoS One. 2016, 11:e0163743. 10.1371\/journal.pone.0163743","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000618","article-title":"Recent progress in Helicobacter pylori treatment","volume":"133","author":"Hu Y","year":"2020","unstructured":"Hu Y, Zhu Y, Lu NH. Recent progress in Helicobacter pylori treatment. Chin Med J. 2020, 133:335-43. 10.1097\/CM9.0000000000000618","journal-title":"Chin Med J"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14872","article-title":"Helicobacter pylori eradication therapy: still a challenge","volume":"13","author":"Hafeez M","year":"2021","unstructured":"Hafeez M, Qureshi ZA, Khattak AL, Saeed F, Asghar A, Azam K, Khan MA. Helicobacter pylori eradication therapy: still a challenge. Cureus. 2021, 13:e14872. 10.7759\/cureus.14872","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68987-the-efficacy-of-probiotics-in-the-management-of-helicobacter-pylori-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:47Z","timestamp":1707507287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68987-the-efficacy-of-probiotics-in-the-management-of-helicobacter-pylori-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,17]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.20483","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,17]]}}}